Doximity, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Doximity, Inc. (DOCS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $6.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $6.60M, a 72.15% decline year-over-year.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $20.50M, a 78.05% decline year-over-year.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $40.80M, a 10.13% decline year-over-year.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $33.70M, a 7.16% decline year-over-year.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $118.70M, a 38.78% decline from fiscal 2025.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $193.90M, a 94.87% increase from fiscal 2024.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $99.50M, a 15.96% decline from fiscal 2023.
- Doximity, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $118.40M, a 77.30% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.60M 10-Q · filed 2026-08-06 | $27.10M derived: sum of 2 quarters · filed 2026-08-06 | $67.90M derived: sum of 3 quarters · filed 2026-08-06 | $101.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-19 | $61.30M derived: sum of 2 quarters · filed 2026-05-19 | $95.00M derived: sum of 3 quarters · filed 2026-05-19 | $118.70M 10-K · filed 2026-05-19 |
| 2025-12-31 | $40.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | $74.50M derived: sum of 2 quarters · filed 2026-02-05 | $98.20M 10-Q · filed 2026-02-05 | $191.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $33.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $57.40M 10-Q · filed 2025-11-06 | $150.80M derived: sum of 3 quarters · filed 2026-08-06 | $196.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.70M 10-Q · filed 2026-08-06 | $117.10M derived: sum of 2 quarters · filed 2026-08-06 | $162.50M derived: sum of 3 quarters · filed 2026-08-06 | $198.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $93.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-19 | $138.80M derived: sum of 2 quarters · filed 2026-05-19 | $175.10M derived: sum of 3 quarters · filed 2026-05-19 | $193.90M 10-K · filed 2026-05-19 |
| 2024-12-31 | $45.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | $81.70M derived: sum of 2 quarters · filed 2026-02-05 | $100.50M 10-Q · filed 2026-02-05 | $125.30M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-09-30 | $36.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $55.10M 10-Q · filed 2025-11-06 | $79.90M derived: sum of 3 quarters · filed 2026-05-19 | $92.80M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-06-30 | $18.80M 10-Q · filed 2025-08-07 | $43.60M derived: sum of 2 quarters · filed 2026-05-19 | $56.50M derived: sum of 3 quarters · filed 2026-05-19 | $79.80M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-03-31 | $24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-19 | $37.70M derived: sum of 2 quarters · filed 2026-05-19 | $61.00M derived: sum of 3 quarters · filed 2026-05-19 | $99.50M 10-K · filed 2026-05-19 |
| 2023-12-31 | $12.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $36.20M derived: sum of 2 quarters · filed 2025-02-06 | $74.70M 10-Q · filed 2025-02-06 | $107.80M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-09-30 | $23.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $61.80M 10-Q · filed 2024-11-07 | $94.90M derived: sum of 3 quarters · filed 2025-05-20 | $120.00M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-06-30 | $38.50M 10-Q · filed 2024-08-08 | $71.60M derived: sum of 2 quarters · filed 2025-05-20 | $96.70M derived: sum of 3 quarters · filed 2025-05-20 | $120.20M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-03-31 | $33.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-20 | $58.20M derived: sum of 2 quarters · filed 2025-05-20 | $81.70M derived: sum of 3 quarters · filed 2025-05-20 | $118.40M 10-K · filed 2025-05-20 |
| 2022-12-31 | $25.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $48.60M derived: sum of 2 quarters · filed 2024-02-08 | $85.30M 10-Q · filed 2024-02-08 | $200.00M derived: sum of 4 quarters · filed 2024-05-23 |
| 2022-09-30 | $23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | $60.20M 10-Q · filed 2023-11-09 | $174.90M derived: sum of 3 quarters · filed 2024-05-23 | $374.80M derived: sum of 4 quarters · filed 2024-05-23 |
| 2022-06-30 | $36.70M 10-Q · filed 2023-08-08 | $151.40M derived: sum of 2 quarters · filed 2024-05-23 | $351.30M derived: sum of 3 quarters · filed 2024-05-23 | $477.90M derived: sum of 4 quarters · filed 2024-05-23 |
| 2022-03-31 | $114.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-23 | $314.60M derived: sum of 2 quarters · filed 2024-05-23 | $441.20M derived: sum of 3 quarters · filed 2024-05-23 | $521.60M 10-K · filed 2024-05-23 |
| 2021-12-31 | $199.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $326.50M derived: sum of 2 quarters · filed 2023-02-09 | $406.90M 10-Q · filed 2023-02-09 | $440.50M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-09-30 | $126.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $207.00M 10-Q · filed 2022-11-10 | $240.60M derived: sum of 3 quarters · filed 2023-05-26 | $245.80M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-06-30 | $80.40M 10-Q · filed 2022-08-05 | $114.00M derived: sum of 2 quarters · filed 2023-05-26 | $119.20M derived: sum of 3 quarters · filed 2023-05-26 | $132.50M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-03-31 | $33.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $38.80M derived: sum of 2 quarters · filed 2023-05-26 | $52.10M derived: sum of 3 quarters · filed 2023-05-26 | $52.60M 10-K · filed 2023-05-26 |
| 2020-12-31 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $18.50M derived: sum of 2 quarters · filed 2022-02-09 | $19.00M 10-Q · filed 2022-02-09 | |
| 2020-09-30 | $13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | $13.80M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $3.00M 10-K · filed 2022-05-27 |